Clifton / DHA
Closest to you4.8(1,033)
3rd Floor, 4C, Khayaban-e-Tanzeem, Tauheed Commercial Area, DHA Phase-5
What is Ozempic and how does it work?
Ozempic and Wegovy contain semaglutide, which copies GLP-1, a hormone your gut releases after a meal. It signals fullness to the brain and slows digestion, so cravings ease and you feel satisfied with less food. Both are made by Novo Nordisk and given as a once-weekly pen injection. They differ in their licences: Ozempic is approved for type 2 diabetes, and Wegovy, at its own doses, for weight management alongside a reduced-calorie diet and more activity.
Ozempic benefits
- Calmer appetite: cravings ease, so smaller meals feel satisfying.
- Once a week: one quick pen injection at home, on the same day each week.
- Steady loss: weight comes off gradually over months, with your doctor watching.
- Backed by large trials: its medicine has been tested in thousands of adults.
- Better blood sugar: it lowers raised blood sugar, which is why Ozempic is used for type 2 diabetes.
- Novo Nordisk’s own pens: prescribed, dosed and followed up by our doctors.
Ozempic for weight loss
Weight-loss injections are for adults whose weight affects their health, not for losing a few kilos before an event. Licences abroad cover adults with a BMI of 30 or more, or 27 or more with a weight-related problem such as high blood pressure, type 2 diabetes or sleep apnoea. Health risks start at a lower weight for South Asian people, so guidelines such as the UK’s NICE use lower cut-offs, with obesity from a BMI of 27.5. Your doctor also looks at your waist, blood sugar and history, and explains whether Ozempic or Wegovy suits you.
Ozempic before and after
Change is gradual: most people notice smaller portions first, then their clothes fitting differently over the following months. In the STEP 1 trial, adults taking the medicine at the Wegovy dose of 2.4 mg a week, with lifestyle support, lost about 15% of their weight on average over 68 weeks, against 2.4% on placebo; results vary from person to person. Our patients share their own stories in the videos below.
Ozempic price in Pakistan
Ozempic and Wegovy cost from Rs 45,000 a month, the same at all 12 of our clinics. To compare every injection we offer, see our weight loss injection price in Pakistan list.
Month 1: 0.25 mg
Starting dose · 4 weekly doses of Ozempic or Wegovy
Rs 45,000 for the month
Month 2: 0.5 mg
4 weekly doses, if you are coping well
Rs 50,000 for the month
Month 3: 1 mg
4 weekly doses, if your doctor raises it
Rs 55,000 for the month
Free consultation first · Any current offer is explained at the clinic
Looking for a lower-cost option? Our semaglutide injection has the same active medicine, from Rs 6,995 a dose, or Rs 22,384 for the first four weeks. It is a DRAP-registered product from another leading pharmaceutical company, not Novo Nordisk, and your doctor explains the difference.
Who shouldn’t have Ozempic or Wegovy?
They are not for you if you are pregnant, breastfeeding or hoping to conceive within two months, or if you or a close relative has had medullary thyroid cancer or MEN 2 syndrome. Past pancreatitis, gallbladder disease, severe stomach-emptying problems, diabetic eye disease, or diabetes medicines that can cause low blood sugar all need a careful review first.
Your Ozempic or Wegovy plan, step by step
- Free consultation: a doctor reviews your BMI, health, medicines and goals, with tests if needed.
- Prescription: if Ozempic or Wegovy is right for you, the doctor explains the pen, dose and plan.
- Your first pen: our team shows you how to inject into your belly, thigh or upper arm, once a week.
- Step-up dosing: you start at 0.25 mg, raised no faster than every four weeks while you cope well.
- Follow-up: regular check-ins on progress and side effects, plus lifestyle coaching.
Results and side effects
Appetite often changes within the first weeks, while weight comes off steadily as the dose rises. Nausea and diarrhoea are the most common side effects, along with vomiting, constipation and headache; they tend to be mild, come mostly after each dose rise and fade with time. Results last as long as the habits and, for many, the treatment: a year after stopping in the STEP 1 trial, about two-thirds of the lost weight had returned, so we plan maintenance with you.
Aftercare
- Eat slowly; skip greasy, heavy meals
- Keep well hydrated every day
- Move more, at a pace that suits you
- Tell us about lasting tummy pain at once
Why choose Cutera Aesthetics
- Medically supervised: your programme is prescribed and monitored by our qualified doctors, with regular check-ins.
- Free consultation: an honest assessment, a clear plan and its full cost before you commit to anything.
- Ozempic near you: at all 12 clinics in 7 cities, at the same price. Find your nearest clinic.
Sources
- US National Library of Medicine. WEGOVY (semaglutide) injection and tablets: prescribing information (DailyMed). Novo Nordisk label: approved uses, dosing, boxed warning and safety.
- US National Library of Medicine. OZEMPIC (semaglutide) injection: prescribing information (DailyMed). Approved for type 2 diabetes.
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine, 2021; 384(11): 989–1002.
- Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism, 2022; 24(8): 1553–64.
- Aronne LJ, Horn DB, le Roux CW, et al. Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). New England Journal of Medicine, 2025.
- DRAP. Rapid Alert I/S/07-23-24: suspected falsified GLP-1 receptor agonists.
- WHO. Medical Product Alert N°2/2024: falsified Ozempic (semaglutide).
- National Institute for Health and Care Excellence. Overweight and obesity management (NG246).
